Name: UMIN ID:
Unique ID issued by UMIN | UMIN000036489 |
---|---|
Receipt number | R000040472 |
Scientific Title | A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for cisplatin containing regimen |
Date of disclosure of the study information | 2019/04/15 |
Last modified on | 2024/04/15 10:04:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/04/12 16:28:21 | ||
2 | Update | 2019/04/12 16:30:29 | Anticipated trial start date Last follow-up date |
|
3 | Update | 2019/08/20 12:21:51 | Recruitment status Date of IRB |
|
4 | Update | 2021/06/08 15:30:04 | Recruitment status |
|
5 | Update | 2022/04/14 10:24:55 | Number of participants that the trial has enrolled |
|
6 | Update | 2024/04/15 10:02:05 | Recruitment status |
|
7 | Update | 2024/04/15 10:04:57 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |